Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale President and CEO sold 27,750 shares at an average $27.23 ($755,517)
  2. 4 Open-market sale Chief Administrative Officer sold 1,981 shares at $25.29 ($50,096)
  3. 4 Open-market sale Chief Medical Officer sold 2,802 shares at $25.29 ($70,857)
  4. 4 Open-market sale CFO sold 2,424 shares at $25.29 ($61,298)
  5. 4 Open-market sale 10% owner sold 38,964 shares at $26.75 ($1,042,384)
  6. 8-K Event Executive or director change
  7. 4 Open-market sale 10% owner sold 117,957 shares at an average $26.28 ($3,099,693)
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 4 Open-market sale 10% owner sold 234,271 shares at an average $26.28 ($6,156,029)
  10. 8-K Event Material agreement
  11. 4 Open-market sale 10% owner sold 145,422 shares at an average $28.51 ($4,146,549)
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Open-market sale Director sold 17,915 shares at an average $28.38 ($508,343)
  14. 4 Open-market sale 10% owner sold 114,035 shares at an average $30.21 ($3,444,984)
  15. 4 Open-market sale 10% owner sold 148,635 shares at an average $29.42 ($4,372,175)
  16. 4 Open-market sale 10% owner sold 152,813 shares at an average $29.46 ($4,502,337)
  17. 4 Open-market sale 10% owner sold 36,512 shares at an average $28.34 ($1,034,707)
  18. 4 Open-market sale Chief Medical Officer sold 30,000 shares at $30.00 ($900,057)
  19. 8-K Event Executive or director change
  20. SC 13G/A Stake Amended Statement of Ownership

Page 18 of 41 · 806 filings